John R. Hurst, MD, PhD, explains how BEAM-302 gene editing targets both lung and liver disease in alpha-1 antitrypsin deficiency.
John R. Hurst, MD, PhD
Advertisement
John R. Hurst, MD, PhD, is the pro vice provost of international health at University College London.
Articles by John R. Hurst, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
Fragmented Care, Financial Strain, Gender Gaps Define Life With COPD
3
Primary Care Capacity Gaps Threaten Respiratory Prevention
4
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
5